Cytokines in Gaucher's disease

European Cytokine Network

Volumn 10, Issue 2, 1999, Pages 205-210

  Barak, Vivian ^a   Acker, Mehmet ^a   Nisman, Benjamin ^a   Kalickman, Ina ^a   Abrahamov, Ayala ^b   Zimran, Ari ^b   Yatziv, Shaul ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

Antagonist; Cytokines; Gaucher's disease; Receptor

Indexed keywords

CYTOKINE; GLYCOSPHINGOLIPID; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; BONE MARROW; BONE NECROSIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; GAUCHER DISEASE; GENE MUTATION; GENE OVEREXPRESSION; HEPATOSPLENOMEGALY; HOMOZYGOSITY; HUMAN; MACROPHAGE; MONONUCLEAR PHAGOCYTE; PRESCHOOL CHILD; SCHOOL CHILD;

CHEMOTAXIS, LEUKOCYTE; CHILD, PRESCHOOL; CYTOKINES; GAUCHER DISEASE; GENOTYPE; HUMANS; HYPERGAMMAGLOBULINEMIA; INFANT; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; INTERLEUKIN-6; POINT MUTATION; RECEPTORS, INTERLEUKIN-2; SEVERITY OF ILLNESS INDEX; SIALOGLYCOPROTEINS; SOLUBILITY; SPLENECTOMY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032805835     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. 1. Zimran A, Kay A, Gelbart T, Garver P, Thurston D, Saven A, Beutler E. 1992. Gaucher disease. Clinical, laboratory, radiologic and genetic features of 53 patients. Medicine (Baltimore) 71: 337.
2. 2. Beutler E. 1992. Gaucher disease: new molecular approaches to diagnosis and treatment. (Review) Science 256: 794.
3. 3. Horowitz M, Zimran A. 1994. Mutations causing Gaucher disease. (Review) Hum. Mutat. 3: 1.
4. 4. Trotta P P. 1991. Cytokines: an overview. (Review) Am. J. Reprod. Immunol. 25: 137.
5. 5. Whicher J T, Evans S W. 1990. Cytokines in disease. (Review) Clin. Chem. 36: 1269.
6. 6. Barak V. 1995. Soluble cytokine receptors in disease. (Review) Isr. J. Med. Sci. 31: 565.
7. 7. Gilbert S H, Weinreb N. 1976. Increased circulating levels of Transcobalamine II in Gaucher disease. N. Engl. J. Med. 295: 1096.
8. 8. Lieberman J, Beutler E N. 1976. Elevation of serum angiotensin converting enzyme in Gaucher disease. N. Engl. J. Med. 294: 1442.
9. 9. Ockerman P A, Kohlin P. 1969. Tissue acid hydrolase activities in Gaucher disease. Clin. Chem. 15: 61.
10. 10. Hollak C E, van Weely S, van Oers MH, Aerts J M. 1994. Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J. Clin. Invest. 93: 1288.
11. 11. Zimran A, Sorge J, Gross E, Kubitz M, Weste Beutler E. 1989. Prediction of severity of Gaucher's disease by identification of mutations at DNA level. Lancet ii: 349.
12. 12. Barak V, Levi-Shaffer F, Nisman B, Nagler A. 1995. Cytokine disregulation in chronic graft versus host disease. Leuk. Lymphoma 17: 169.
13. 13. Barak V, Barak Y, Levine J, Nisman B, Roisman I. 1995. Changes in interleukin-1β and soluble interleukin-2 receptor levels in CSF and serum of schizophrenic patients. J Basic Clin. Physiol. Pharmacol. 6: 61.
14. 14. Mistry P K, Grant I, Cox T M. Phenotypic diversity of Gaucher disease in a pair of identical tweens. European Working Group on Gaucher disease, Trieste 1994 (abst).
15. 15. Gery I, Zigler J S, Brady R O, Barranger J A. 1981. Selective effects of glucocerebrosidase (Gaucher's storage material) on macrophage cultures. J. Clin. Invest. 68: 1182.
16. 16. Dinarello C A. 1994. The biological properties of interleukin-1. (Review) Eur. Cytokine Netw. 5: 517.
17. 17. Manolagas S C, Jilka R L. 1995. Bone marrow, cytokines and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. (Review) N. Engl. J. Med. 332: 305.
18. 18. Stowens D W, Teitelbaum S L, Kahn A J, Barranger J A. 1985. Skeletal complications in Gaucher disease. Medicine 64: 310.
19. 19. Arend W P. 1993. Interleukin-1 receptor antagonist (IL-1Ra). (Review) Adv. Immunol. 54: 167.
20. 20. Dinarello C A. 1991. Interleukin-1 and interleukin-1 antagonism. (Review) Blood 77: 1627.
21. 21. Yatziv S, Aker M, Barif G, Barak V. 1996. Cytokines in Gaucher's disease. World Pediatrics and Child Care 6: 18.
22. 22. Brach M A, Herrmann F. 1992. Interleukin-6: presence and future. (Review) Int. J. Clin. Lab. Res. 22: 143.
23. 23. Bataille R, Jourdan M, Zhang X G, et al. 1981. Serum levels of interleukin-6, a potent myeloma cell growth factor, as a reflection of dyscrasias. J. Clin. Invest. 14: 1182.
24. 24. Schoenfeld Y, Beresovsky A, Zharhary D, Tomer Y, Swissa M, Sela E, Zimran A, Zevin S, Gilburd B, Blank M. 1995. Natural autoantibodies in sera of patients with Gaucher's disease. J. Clin. Immunol. 15: 363.
25. 25. Schoenfeld Y, Berliner S, Pinkhas J, Beutler E. 1980. The association of Gaucher's disease and dysproteinemias. Acta Haematol. 64: 241.
26. 26. Hughes F J, Howells G L. 1993. Interleukin-6 inhibits bone formation in vitro. Bone Miner. 21: 21.
27. 27. Michelakakis H, Spanou K, Kondyli A, Dimitriou E, van Weely S, Hollak C, van Oers R, Aerts H. TNF-α plasma levels in Gaucher and other lysosomal storage diseases. Abstract presented at European Study Group on Lysosmal Diseases. September 16-19, 1995.
28. 28. Tracey K J, Vlassara H, Cerami A. 1989. Cachectin/tumor necrosis factor. (Review) Lancet 1: 1122.
29. 29. Allen M J, Myer B J, Khokher A M, Rushton N, Cox T M. 1997. Proinflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of IL-6 and IL-10. Q. J. Med. 90: 19.
30. 30. Van Damme J. Interleukin-8 and related molecules. The Cytokine Handbook. A Thompson (ed.), 201-215, Academic Press, 1991.
31. 31. Taniguchi T, Minami Y. 1993. The IL-2/IL-2R system: a current overview. (Review) Cell 73: 5.
32. 32. Pui C H. 1993. Serum interleukin-2 receptor: clinical and biological implications. Leukemia 3: 323.
33. 33. Schoenfeld Y, Gallant L A, Shaklai M, et al. 1982. Gaucher's disease, a disease with chronic stimulation of the immune system. Arch. Pathol. Lab. Med. 106: 388.
34. 34. Bogdan C, Vodovotz Y, Nathan C. 1991. Macrophage deactivation by interleukin-10. J Exp. Med. 174: 1549.
35. 35. Lichtenstein M, Zimran A, Horowitz M. 1997. Cytokine mRNA in Gaucher's disease. Blood Cells Mol. Dis. 23: 395.